Dirks R P, Jansen H J, Onnekink C, De Jonge R J, Bloemers H P
Department of Biochemistry, University of Nijmegen, The Netherlands.
Eur J Biochem. 1993 Sep 1;216(2):487-95. doi: 10.1111/j.1432-1033.1993.tb18167.x.
The human c-sis gene encodes the B chain of platelet-derived growth factor (PDGF), a potent mitogen for cultured cells of mesenchymal origin. PDGF is stored in the alpha-granules of blood platelets, which are derived from bone marrow megakaryocytes and lack transcriptional machinery. Human myeloid leukemia cell line K562 can be used as a model for megakaryocytes. Phorbol-ester-mediated megakaryocytic differentiation of K562 cells is accompanied by more than 200-fold increase in the c-sis mRNA level. We have now localized transcriptional enhancers at -8.6 kb and -9.9 kb relative to the human c-sis gene transcription start site. The enhancer at -8.6 kb increases activity of the c-sis promoter by 40-60-fold specifically in K562 cells and comaps with a DNase-I-hypersensitivity (DH) site. The enhancer at -9.9 kb increases c-sis promoter activity by 5-10-fold in K562 cells and DH at that site accompanies phorbol-ester-induced megakaryocytic differentiation. In phorbol-ester-treated K562 cells the two enhancers may be negatively influenced by a silencer that comaps with DH at -10.7/-11.0 kb. Reporter gene analysis predicted that combined activity of the upstream enhancers and the c-sis promoter may result in 100-1000-fold higher promoter activity in phorbol-ester-treated K562 cells compared with untreated cells, which can fully explain the more than 200-fold increase in c-sis mRNA level. DH at -8.6 kb and -9.9 kb was also detected in human fibroblasts and in the carcinoma cell lines HeLa and PC3, which express, respectively, undetectable, low and high levels of c-sis mRNA. Although the individual DH sites displayed 4-10-fold enhancer activity in all these cells, they lost most of their biological activity when combined in a larger fragment. In addition we localized (part of) a new transcription unit at approximately 13 kb upstream of the c-sis transcription start site. The corresponding 0.45-kb sis upstream region (sur) transcript is constitutively expressed in all cell lines examined. The expression of the sur transcript is independent of the expression of c-sis mRNA and of the pattern of DH sites far upstream of the c-sis gene. Thus, at present, there is no indication that the upstream DH sites are involved in regulation of expression of the sur gene.
人类c-sis基因编码血小板衍生生长因子(PDGF)的B链,PDGF是一种对间充质来源的培养细胞有强大促有丝分裂作用的物质。PDGF储存在血小板的α颗粒中,血小板来源于骨髓巨核细胞,缺乏转录机制。人类髓系白血病细胞系K562可作为巨核细胞的模型。佛波酯介导的K562细胞向巨核细胞分化伴随着c-sis mRNA水平增加200多倍。我们现已将转录增强子定位在相对于人类c-sis基因转录起始位点-8.6 kb和-9.9 kb处。-8.6 kb处的增强子可使c-sis启动子的活性在K562细胞中特异性增加40 - 60倍,并且与一个核酸酶I超敏(DH)位点共定位。-9.9 kb处的增强子可使K562细胞中c-sis启动子活性增加5 - 10倍,该位点的DH伴随着佛波酯诱导的巨核细胞分化。在经佛波酯处理的K562细胞中,这两个增强子可能受到一个与-10.7 / -11.0 kb处DH共定位的沉默子的负面影响。报告基因分析预测,与未处理细胞相比,上游增强子和c-sis启动子的联合活性可能导致经佛波酯处理的K562细胞中启动子活性提高100 - 一千倍,这可以充分解释c-sis mRNA水平增加200多倍的现象。在人类成纤维细胞以及癌细胞系HeLa和PC3中也检测到了-8.6 kb和-9.9 kb处的DH,它们分别表达不可检测、低水平和高水平的c-sis mRNA。尽管单个DH位点在所有这些细胞中显示出4 - 10倍的增强子活性,但当它们组合在一个更大的片段中时,大部分生物学活性丧失。此外,我们在c-sis转录起始位点上游约13 kb处定位了一个新转录单元(的一部分)。相应的0.45 kb的sis上游区域(sur)转录本在所有检测的细胞系中均组成性表达。sur转录本的表达与c-sis mRNA的表达以及c-sis基因上游远处DH位点的模式无关。因此,目前没有迹象表明上游DH位点参与sur基因表达的调控。